Fedorova_2017_Neurology_88_775

Reference

Title : Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study - Fedorova_2017_Neurology_88_775
Author(s) : Fedorova TD , Seidelin LB , Knudsen K , Schacht AC , Geday J , Pavese N , Brooks DJ , Borghammer P
Ref : Neurology , 88 :775 , 2017
Abstract :

OBJECTIVE: To investigate systemic levels of acetylcholinesterase in early Parkinson disease (PD) with 11C-donepezil PET, a potential marker of parasympathetic innervation.
METHODS: This was a cross-sectional study with 19 patients with early-stage PD (disease duration 1.5 +/- 0.6 years) and 16 age-matched controls who had clinical assessments, olfaction tests, and 11C-donepezil PET to measure acetylcholinesterase density in peripheral organs.
RESULTS: The patients with PD showed significantly reduced 11C-donepezil uptake in the small intestine (-14%, p = 0.018), colon (-22%, p < 0.001), and kidneys (-14%, p = 0.028). No difference in myocardial or pancreatic acetylcholinesterase levels was seen. CONCLUSION: We found significantly decreased 11C-donepezil signal in the intestine and kidneys of patients with early PD, suggesting that parasympathetic denervation is present early in the disease course.

PubMedSearch : Fedorova_2017_Neurology_88_775
PubMedID: 28100726

Related information

Citations formats

Fedorova TD, Seidelin LB, Knudsen K, Schacht AC, Geday J, Pavese N, Brooks DJ, Borghammer P (2017)
Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study
Neurology 88 :775

Fedorova TD, Seidelin LB, Knudsen K, Schacht AC, Geday J, Pavese N, Brooks DJ, Borghammer P (2017)
Neurology 88 :775